Richard Scott Struthers - 18 Apr 2024 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
18 Apr 2024
Net transactions value
$0
Form type
4
Filing time
22 Apr 2024, 17:23:10 UTC
Previous filing
17 Apr 2024
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Gift $0 -350 -0.14% $0.000000 257,485 18 Apr 2024 Direct F1
holding CRNX Common Stock 570,805 18 Apr 2024 By Family Trust 1
holding CRNX Common Stock 110,000 18 Apr 2024 By Family Trust 2
holding CRNX Common Stock 110,000 18 Apr 2024 By Family Trust 3
holding CRNX Common Stock 110,000 18 Apr 2024 By Family Trust 4
holding CRNX Common Stock 1,000 18 Apr 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift made by the Reporting Person for no consideration.